Kelley Shannon T's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Aug 20, 2026
- Accession no.
- 0001628280-26-058256
- Filed
- Aug 20, 2026, 4:20 PM ET
- Trade date
- Aug 17, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $341.9K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kelley Shannon TCIK 0002034056 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | SSaleDisposed | −664 | $514.97 | −$341,940.08 | 11,474 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.